Drugs / Novolin 30R
last change Aug 2021 re-read 3 minutes ago

Novolin 30R

Developed for
type 2 diabetes mellitus
Investigated by
Qianfoshan Hospital

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT03030300 Jan 2008 → Feb 2015 type 2 diabetes mellitus Qianfoshan Hospital Completed No outcome recorded
Comparator or background therapy1 trial
— NCT01833559 Background Jun 2012 → May 2021 gestational diabetes First Affiliated Hospital, Sun Yat-Sen University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Novolin 30R “Novolin 30R” NCT01833559 ↗
1

NCT03030300 ↗